Sam Englebardt and Megan McGill

Sam Englebardt and Megan McGill

Sam Englebardt is a media and technology investor and content producer who has created, acquired and/or financed a broad range of traditional and digital businesses and dozens of video games, films and television shows over the past decade.

Englebardt is a Co-Founder and Partner at Galaxy Digital and a founding General Partner of Galaxy’s Interactive division. Now investing from its second venture fund, with a combined $650mm of AUM, Galaxy Interactive focuses exclusively on companies operating at the intersection of content, finance and decentralized technology, with particular emphasis on video game studios, NFTs, social platforms and financial marketplaces. 

Englebardt’s involvement with Galaxy reflects his deep interest in the intersection of content, consciousness and exponential technologies. In addition to the Galaxy Interactive portfolio, he was an early investor in Eyefluence, an eye-tracking technology company that was sold to Google and he has been an advisor to several start-ups in the mixed-reality space, including VR company, The Void. He has also been an active crypto and blockchain investor for years, after first buying bitcoin in 2013 and ethereum in 2016. 

Prior to Galaxy Digital, Englebardt was a Partner and Managing Director at Lambert Media Group (LMG) from 2007 - 2016, where he sourced and managed a portfolio of media-sector private equity investments including Rave Cinemas (sold to Cinemark in 2013). He has been a prolific content producer throughout his career and spent three years running LMG portfolio company, Demarest Films. His recent live-action projects include the acclaimed John Le Carre projects, The Night Manager and A Most Wanted Man.

A licensed attorney in California, Englebardt earned his J.D. from Harvard Law School and studied philosophy, political science and economics at Oxford University and the University of Colorado at Boulder, from which he graduated summa cum laude and Phi Beta Kappa.

Dr. Megan McGill is a physician-scientist working in biotech.  She is currently the VP of Strategy and Transactions at BridgeBio, a biopharmaceutical company focused on creating medicines for patients with genetic diseases and cancers with clear genetic drivers.

Megan received a BA, magna cum laude, from the University of Pennsylvania in neuroscience, chemistry and music.  She completed her MD and PhD degrees at New York University with a PhD in neuroimaging and MRI physics, and was elected to Alpha Omega Alpha Honor Medical Society. Megan trained as a radiologist at NYU Langone Medical Center and previously held roles at McKinsey & Co. in the firm's healthcare practice and Regenxbio, a gene therapy company. She is a founding member and co-chair of the International Crisis Group's Women's Alliance for Peace and sits on the board of the Harmony Program.

Megan lives in New York City with her fiance Sam Englebardt, 14 year-old son Jasper and their cockapoo, Pi.